Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E

Biochemistry

Volumn 46, Issue 49, 2007, Pages 14316-14324

  Kukreja, Roshan V ^a   Singh, Bal Ram ^a  

^a UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM NEUROTOXIN COMPLEX; ENDOPEPTIDASE ACTIVITY; PROTEOLYTIC DIGESTION; STRUCTURAL STABILITY;

LIGHT; NEURONS; OPTIMIZATION; PHYSIOLOGY; PROTEOLYSIS; TOXIC MATERIALS;

PROTEINS;

NEUROTOXIN; NEUROTOXIN ASSOCIATED PROTEIN; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; ENZYME ACTIVITY; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN STRUCTURE; TEMPERATURE;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; CIRCULAR DICHROISM; DRUG STABILITY; ENDOPEPTIDASES; HEAT; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN STRUCTURE, TERTIARY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

CLOSTRIDIUM BOTULINUM;

EID: 37049016293     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701564f     Document Type: Article

References (49)

1. Lamanna, C. (1959) The most poisonous poison, Science 130, 763-772.
2. Singh, B. R. (2000) Intimate details of the most poisonous poison, Nat. Struct. Biol. 7, 617-619.
3. Coffield, J. A. (2003) Botulinum neurotoxin: the neuromuscular junction revisited, Crict. Rev. Neurobiol. 15, 175-195.
4. Klien, A. W. (2004) The therapeutic potential of botulinum toxin, Dermatol. Surg. 30, 452-455.
5. Bhidayasiri, R., and Truong, D. D. (2005) Expanding use of botulinum toxin, J. Neurol. Sci. 235, 1-9.
6. Montecucco, C., and Schiavo, G. (1995) Structure and function of tetanus and botulinum neurotoxins, Q. Rev. Biophys. 28, 423-472.
7. Dressler, D., and Saberi, F. A. (2005) Botulinum toxin: mechanisms of action, Eur. Neurol. 53, 3-9.
8. Tonello, F., Morante, S., Rossetto, O., Schiavo, G., and Montecucco, C. (1996) Tetanus and botulinum neurotoxins, Adv. Exp. Med. Biol. 389, 251-260.
9. Swaminathan, S., Eswaramoorthy, S., and Kumaran, D. (2004) Structure and enzymatic activity of botulinum neurotoxins, Movement Disorders 19, S17-S22.
10. Li, L., and Singh, B. R. (1999) Structure-function relationship of clostridial neurotoxins, J. Toxicol., Toxin Rev. 18, 95-112.
11. Chaddock, J. A., and Marks, P. M. H. (2006) Clostridial neurotoxins: structure-function led design of new therapeutics, Cell. Mol. Life Sci. 63, 540-51.
12. Chen, F., Kuziemko, G. M., and Stevens, R. C. (1998) Biophysical characterization of the stability of the 150 kDa botulinum toxin, the nontoxic component, and the 900-kDa botulinum toxin complex species, Infect. Immun. 66, 2420-2425.
13. Humeau, Y., Doussau, Grant, F., N. J., and Poulain, B. (2000) How botulinum and tetanus neurotoxins block neurotransmitter release, Biochimie 82, 427-46.
14. Inoue, K., Fujinaga, Y., Watanabe, T., Ohyama, T., Takeshi, K., Moriishi, K., Nakajima, H., and Oguma, K. (1996) Molecular composition of Clostridium botulinum type A progenitor toxins, Infect. Immun. 64, 1589-1594.
15. Singh, B. R. (2002) in Scientific and Therapeutic Aspects of Botulinum Toxin (Brin, M. F., Jankovic, J., and Hallet, M., Eds.) pp 75-88, Lipincott Williams and Wilkins, Philadelphia.
16. Ting, P. T., and Freiman, A. (2004) The story of clostridium botulinum: from food poisoning to botox, Clin. Med. 4, 258-261.
17. Li, B., Qian, X., Sarkar, H. K., and Singh, B. R. (1998) Molecular characterization of type E Clostridium botulinum and comparison to other types of Clostridium botulinum, Biochim. Biophys. Acta 1395, 21-1.
18. Sharma, S., and Singh, B. R. (2004) Enhancement of the endopeptidase activity of purified neurotoxins A and E by an isolated component of the native neurotoxin associated proteins, Biochemistry 43, 4791-4798.
19. Fujinaga, Y., Inoue, K., Watanabe, S., Yokota, K., Hirai, Y., Nagamachi, E., and Oguma, K. (1997) The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin, Microbiology 143, 3841-3847.
20. Fujinaga, Y., Inoue, K., Watanabe, S., Sakaguchi, Y., Arimitsu, H., Lee, J .C., Jin, Y., Matsumura, T., Kabumoto, Y., Watanabe, T., and Ohyama, T. (2004) Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes, Microbiology 150, 1529-1538.
21. Arnon, S. S., Schechter, R., Ingelsby, T. V., Henderson, D, A., Bartlett, D. A., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M. T., O'Toole, T., Parker, G., Perl, T. M., Russell, P. K., Swerdlow, D. L., and Tonat, K. (2001) Botulinum toxin as a biological weapon: medical and public health management, JAMA 285, 1059-1070.
22. Shukla, H. D., and Sharma, S. K. (2005) Clostridium botulinum: A bug with beauty and weapon, Crit. Rev. Microbiol. 31, 11-18.
23. Cai, S., Sarkar, H. K., and Singh, B. R. (1999) Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol, Biochemistry 38, 6903-6910.
24. Sakaguchi, G. (1983) Clostridium botulinum toxins, Pharmacol. Ther. 19, 165-194.
25. Singh, B. R. and Zhang, Z. (2004) Novel proteins within the type E botulinum neurotoxin complex, U.S. Patent No. 6,699,966.
26. Singh, B. R., Li, B., and Read, D. (1995) Botulinum versus tetanus neurotoxins: why is botulinum neurotoxin but not tetanus neurotoxin a food poison?, Toxicon 33, 1541-1547.
27. DasGupta, B. R., and Satyamoorthy, V. (1984) Purification and amino acid composition of type A botulinum neurotoxin, Toxicon 22, 415-424.
28. Chang, C., Wu, C., and Yang, J. (1978) Circular dichroic analysis of protein conformation: inclusion of β-turns, Anal. Biochem. 91, 13-31.
29. Fu, F., Lomneth, R. B., Cai, S., and Singh, B. R. (1998) Role of zinc in the structure and toxic activity of botulinum neurotoxin, Biochemistry 37, 5267-5278.
30. Ragone, R., Colonna, G., Bismuto, E., and Irace, G. (1987) Unfolding pathway of myoglobin: effect of denaturants on solvent accessibility to tyrosyl residues detected by second derivative spectroscopy, Biochemistry 26, 2130-2134.
31. Singh, B. R., and DasGupta, B. R. (1989) Structure of heavy and light chain subunits of type A botulinum neurotoxin analyzed by circular dichroism and fluorescence measurements, Mol. Cell. Biochem. 86, 87-95.
32. Singh, B. R., Foley, J., and Lafontaine, C. (1995) Physicochemical and immunological characterization of type E botulinum neurotoxin binding protein purified from Clostridium botulinum, J. Protein Chem. 14, 7-18.
33. Raffestien, S., Marvaud, J. C., Cerrato, R., Dupuy, B., and Popoff, M. (2004) Organization and regulation of neurotoxin genes in Clostridium botulinum and Clostridium tetani, Anaerobe 10, 93-100.
34. Pace, P. N., Shirley, B. A., and Thompson, J. A. (1989) in Protein Structure, a Practical Approach (Chreighton, T. E., Ed.) p 315, IRL Press, New York.
35. Kono, M., Sen, A. C., and Chakravarti, B. (1990) Thermodynamics of thermal and athermal denaturation of gamma-crystallins: changes in conformational stability upon glutathione reaction, Biochemistry 29, 464-470.
36. Kukreja, R., and Singh, B. R. (2005) Biologically active novel conformational state of botulinum, the most poisonous poison, J. Biol. Chem. 280, 39346-39352.
37. Deshpande, S. S., and Damodaran, S. (1989) Heat-induced conformational changes in phaseolin and its relation to proteolysis, Biochim. Biophys. Acta, 998, 179-188.
38. Li, L., and Singh, B. R. (2000) Role of zinc binding in type A botulinum neurotoxin light chain's toxic structure, Biochemistry 39, 10581-10586.
39. Li, L., and Singh, B. R. (2000) Spectroscopic analysis of pH-Induced changes in the molecular features of type A botulinum neurotoxin light chain, Biochemistry 39, 6646-6474.
40. Singh, B. R., and DasGupta, B. R. (1990) Conformational changes associated with the nicking and activation of botulinum neurotoxin type E, Biophys. Chem. 38, 123-130.
41. Ragone, R., Colonna, G., Balestrieri, C., Servillo, L., and Irace, G. (1984) Determination of Tyrosine exposure in proteins by Second-Derivative Spectroscopy, Biochemistry 23, 1871-1875.
42. Singh, B. R., Wasacz, F. M., Strand, S., Jacobsen, R. J., and DasGupta, B. R. (1990) Structural Analysis of Botulinum Neurotoxin type A and E in aqueous and nonpolar solvents by Fourier Transform Infrared, Second Derivative UV Absorption, and Circular Dichroic Spectroscopies, J. Protein Chem. 9, 705-713.
43. Singh, B. R. (2006) Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting, Neurotox. Res. 9, 73-92.
44. Montecucco, C., and Schiavo, G. (1993) Tetanus and botulinum neurotoxins: a new group of zinc proteases, Trends Biochem. Sci. 18, 324-327.
45. Cai, S., and Singh, B. R. (2001) Role of the disulfide cleavage induced molten globule state of type A botulinum neurotoxin in its endopeptidase activity, Biochemistry 50, 15327-15333.
46. Fu, F. N., Sharma, S. K., and Singh, B. R. (1998) A protease-resistant novel hemagglutinin purified from type A Clostridium botulinum, J. Protein Chem. 17, 53-60.
47. Sharma, S. K., and Singh, B. R. (1998) Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis, J. Nat. Toxins 7, 239-253.
48. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., and Stevens, R. C. (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity, Nat. Struct. Biol. 5, 898-902.
49. Woody, M. A., and DasGupta, B. R. (1989) Effect of tetranitromethane on the biological activities of botulinum neurotoxin types A, B and E, Mol. Cell. Biochem. 85, 159-169.